-
Signature
-
/s/ Remie Solano, as Attorney-in-Fact for Gerhard Watzinger
-
Issuer symbol
-
CRWD
-
Transactions as of
-
29 Oct 2021
-
Transactions value $
-
-$1,408,372
-
Form type
-
4
-
Filing time
-
02 Nov 2021, 16:26:43 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CRWD |
Class A common stock |
Conversion of derivative security |
|
+5,000 |
|
|
5,000 |
29 Oct 2021 |
By Clavius Capital LLC |
F1, F2 |
| transaction |
CRWD |
Class A common stock |
Sale |
-$243,904 |
-870 |
-17.4% |
$280.35 |
4,130 |
29 Oct 2021 |
By Clavius Capital LLC |
F2, F3 |
| transaction |
CRWD |
Class A common stock |
Sale |
-$392,694 |
-1,396 |
-33.8% |
$281.3 |
2,734 |
29 Oct 2021 |
By Clavius Capital LLC |
F2, F4 |
| transaction |
CRWD |
Class A common stock |
Sale |
-$709,450 |
-2,514 |
-91.95% |
$282.2 |
220 |
29 Oct 2021 |
By Clavius Capital LLC |
F2, F5 |
| transaction |
CRWD |
Class A common stock |
Sale |
-$56,642 |
-200 |
-90.91% |
$283.21 |
20 |
29 Oct 2021 |
By Clavius Capital LLC |
F2, F6 |
| transaction |
CRWD |
Class A common stock |
Sale |
-$5,680 |
-20 |
-100% |
$284 |
0 |
29 Oct 2021 |
By Clavius Capital LLC |
F2 |
| holding |
CRWD |
Class A common stock |
|
|
|
|
|
2,580 |
29 Oct 2021 |
Direct |
F7 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CRWD |
Class B common stock |
Conversion of derivative security |
$0 |
-5,000 |
-5% |
$0 |
95,000 |
29 Oct 2021 |
Class A common stock |
5,000 |
$0 |
By Clavius Capital LLC |
F2, F8 |
| holding |
CRWD |
Class B common stock |
|
|
|
|
|
100,000 |
29 Oct 2021 |
Class A common stock |
100,000 |
$0 |
By Clavius AP, LLC |
F2, F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
All transactions were executed pursuant to a Rule 10b5-1 plan entered into by the Reporting Person.